Literature DB >> 26931622

Rasagiline prevents cyclosporine A-sensitive superoxide flashes induced by PK11195, the initial signal of mitochondrial membrane permeabilization and apoptosis.

Yuqiu Wu1, Masayo Shamoto-Nagai1, Wakako Maruyama1, Toshihiko Osawa1, Makoto Naoi2.   

Abstract

Rasagiline, a neuroprotective inhibitor of type B monoamine oxidase, prevented PK111195-induced apoptosis in SH-SY5Y cells through inhibition of mitochondrial apoptosis signaling (J Neural Transm 120:1539-1551, 2013, J Neural Transm 122:1399-1407, 2015). This paper presents that PK11195 induced superoxide flashes, the transit production burst, mediated by cyclosporine A-sensitive membrane permeability transition. Rasagiline prevented superoxide flashes, calcium efflux, and cell death by PK11195. Regulation of the initial pore formation at the inner mitochondrial membrane was confirmed as the decisive mechanism of neuroprotection by rasagiline.

Entities:  

Keywords:  Mitochondrial permeability transition; Neuroprotection; Rasagiline; Superoxide flashes

Mesh:

Substances:

Year:  2016        PMID: 26931622     DOI: 10.1007/s00702-016-1531-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  10 in total

Review 1.  Explaining ADAGIO: a critical review of the biological basis for the clinical effects of rasagiline.

Authors:  Peter Jenner; J William Langston
Journal:  Mov Disord       Date:  2011-09-23       Impact factor: 10.338

Review 2.  Mitochondrial membrane permeabilization in cell death.

Authors:  Guido Kroemer; Lorenzo Galluzzi; Catherine Brenner
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 3.  Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets.

Authors:  Orit Bar-Am; Tamar Amit; Moussa B Youdim; Orly Weinreb
Journal:  J Neural Transm (Vienna)       Date:  2015-04-10       Impact factor: 3.575

4.  Modulation of brain mitochondrial function by deprenyl.

Authors:  Analía Czerniczyniec; Juanita Bustamante; Silvia Lores-Arnaiz
Journal:  Neurochem Int       Date:  2005-11-09       Impact factor: 3.921

5.  Chemiluminescence probe with Cypridina luciferin analog, 2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one, for estimating the ability of human granulocytes to generate O2-.

Authors:  M Nakano; K Sugioka; Y Ushijima; T Goto
Journal:  Anal Biochem       Date:  1986-12       Impact factor: 3.365

6.  Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection.

Authors:  Yuqiu Wu; Kimiko Kazumura; Wakako Maruyama; Toshihiko Osawa; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2015-04-12       Impact factor: 3.575

7.  Rasagiline prevents apoptosis induced by PK11195, a ligand of the outer membrane translocator protein (18 kDa), in SH-SY5Y cells through suppression of cytochrome c release from mitochondria.

Authors:  Makoto Naoi; Wakako Maruyama; Hong Yi
Journal:  J Neural Transm (Vienna)       Date:  2013-05-17       Impact factor: 3.575

8.  Mitochondrial flashes: new insights into mitochondrial ROS signalling and beyond.

Authors:  Tingting Hou; Xianhua Wang; Qi Ma; Heping Cheng
Journal:  J Physiol       Date:  2014-07-18       Impact factor: 5.182

9.  Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan.

Authors:  Yukihiro Akao; Wakako Maruyama; Shigeomi Shimizu; Hong Yi; Yoshihito Nakagawa; Masayo Shamoto-Nagai; Moussa B H Youdim; Yoshihide Tsujimoto; Makoto Naoi
Journal:  J Neurochem       Date:  2002-08       Impact factor: 5.372

10.  Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson's Disease with Neuroprotective Potential.

Authors:  John P M Finberg
Journal:  Rambam Maimonides Med J       Date:  2010-07-02
  10 in total
  7 in total

Review 1.  Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease.

Authors:  Éva Szökő; Tamás Tábi; Peter Riederer; László Vécsei; Kálmán Magyar
Journal:  J Neural Transm (Vienna)       Date:  2018-02-07       Impact factor: 3.575

2.  Phytochemicals prevent mitochondrial membrane permeabilization and protect SH-SY5Y cells against apoptosis induced by PK11195, a ligand for outer membrane translocator protein.

Authors:  Yuqiu Wu; Masayo Shamoto-Nagai; Wakako Maruyama; Toshihiko Osawa; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2016-09-17       Impact factor: 3.575

Review 3.  Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson's disease.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2020-01-28       Impact factor: 3.575

4.  Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline.

Authors:  Keiko Inaba-Hasegawa; Masayo Shamoto-Nagai; Wakako Maruyama; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2017-06-02       Impact factor: 3.575

5.  Targeting Mitochondria in Tumor-Associated Macrophages using a Dendrimer-Conjugated TSPO Ligand that Stimulates Antitumor Signaling in Glioblastoma.

Authors:  Anjali Sharma; Kevin Liaw; Rishi Sharma; Ajit G Thomas; Barbara S Slusher; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Biomacromolecules       Date:  2020-08-31       Impact factor: 6.988

Review 6.  The path from mitochondrial ROS to aging runs through the mitochondrial permeability transition pore.

Authors:  Hagai Rottenberg; Jan B Hoek
Journal:  Aging Cell       Date:  2017-07-31       Impact factor: 9.304

Review 7.  Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.